Elastomeric Infusion System Market

Elastomeric infusion systems comprise a network of interconnected pipes that dispense a variety of fluids, ranging from oil and gas to water and chemicals. They are used in a wide range of industries, such as oil and gas, nuclear power generation, chemical production, food processing, beverage production, wind energy, and water disposal. Increasing awareness about the benefits of this type of system, coupled with increasing adoption of these systems across various sectors, are some key factors driving the growth of the elastomeric infusion system market.

The elastomeric infusion system market comprises infusion pumps, tubing sets, connectors, and other associated devices used in administering medications or supplements through a vein (arterial line). This type of system is preferred over traditional methods such as syringes because it provides consistent dosage delivery and eliminates cross-contamination risk. Other advantages include improved patient comfort and reduced staffing requirements.

The elastomeric infusion system market is estimated to be worth USD XX million by 2031, growing at a CAGR of **% during the forecast period. The market is expected to grow significantly owing to the increasing prevalence of diseases such as cancer and chronic obstructive pulmonary disease (COPD), which are treated with elastomeric infusion systems. In addition, increasing awareness about the benefits of using elastomeric infusion systems for treatment is also expected to drive growth in the market.

Some key players in the elastomeric infusion system market include Braun Melsungen AG, Fresenius Kabi AG, Leventon S.A.U., Ambu A/S., Baxter International Inc., Nipro, S&S Med., B. Braun, Wood Young Medical, and Avanos Medical.